Consultation on draft recommendation for inclusion in the Authorisation List
Consultation on draft recommendation for inclusion in the Authorisation List
ECHA regularly assesses the substances from the Candidate List to decide which ones should be included in the Authorisation List (Annex XIV) as a priority. Based on the prioritisation, a number of substances are proposed in the draft recommendation. This prioritisation is primarily based on the information in the registration dossiers on uses and volumes of the substance in the scope of authorisation. Therefore, registrants are encouraged to keep their registration dossiers up to date.
Downstream users of substances are encouraged to communicate relevant information regarding their uses and conditions of use up the supply chain to ensure that registrants have sufficient information to update their registration dossiers.
The three months consultation on ECHA's draft recommendation typically runs once every 1.5 to 2 years.
Information on which documents are relevant for this consultation, the kind of comments sought from interested parties and about confidentiality are provided at:
During the consultation, there is also a parallel call for information by the European Commission on the possible socio-economic consequences of the inclusion of the substances in the Authorisation List.
Information and documents on previous consultations are available on theRecommendation for inclusion in the Authorisation List.
Consultations close at 23:59Helsinki time
| Barium diboron tetraoxide | 237-222-4 | 13701-59-2 | 07/02/2024 | 07/05/2024 |  | Details |
| Bis(2-ethylhexyl) tetrabromophthalate covering any of the individual isomers and/or combinations thereof | - | - | 07/02/2024 | 07/05/2024 | | Details |
| Diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide | 278-355-8 | 75980-60-8 | 07/02/2024 | 07/05/2024 | | Details |
| Melamine | 203-615-4 | 108-78-1 | 07/02/2024 | 07/05/2024 | | Details |
| S-(tricyclo[5.2.1.0-(2,6)]deca-3-en-8(or 9)-yl) O-(isopropyl or isobutyl or 2-ethylhexyl) O-(isopropyl or isobutyl or 2-ethylhexyl) phosphorodithioate | 401-850-9 | 255881-94-8 | 07/02/2024 | 07/05/2024 | | Details |
- General approach for prioritisation of SVHCs for Inclusion in the list of substances subject to Authorisation used in Recommendations [PDF][EN]
- General approach for prioritisation of SVHCs: practical implementation examples [PDF][EN]
- General approach for preparation of draft Annex XIV entries for substances to be included in Annex XIV [PDF][EN]
- Setting LADs - Practical implementation of the Annex XIV entries approach [PDF][EN]
- Generic exemptions from the authorisation requirement [PDF][EN]
- ECHA's general responses on issues commonly raised in consultations on draft recommendations [PDF][EN]